Russia-Ukraine crisis: Indian pharma exporters seek clarity on pending orders
PremiumOfficials said that they are closely monitoring the developments and ensuring the well-being of their staff in that region is the first and foremost priority.
HYDERABAD : Indian pharmaceutical companies are vacillating about their exports to Ukraine, as the Russia-Ukraine crisis changes rapidly, after Russian President Vladimir Putin announced a special military operation in the east Ukrainian areas.
The pharmaceutical companies are waiting to witness the situation further on dispatching fresh orders to Ukraine and some of the CIS countries, industry sources confirmed.
India exported over USD 181 million worth of pharmaceutical goods to Ukraine in FY 21, nearly 44% growth over the previous year, while Russia contributed nearly USD 591 million last fiscal with a growth of 6.95% compared to a year before, according to Pharmaceuticals Export Promotion Council of India (Pharmexcil), body under the Department of Commerce.
An official of Dr Reddy's Laboratories said they are closely monitoring the developments and ensuring the well-being of their staff in that region is the first and foremost priority.
"We have had a strong presence in the region for over three decades. Ensuring the well-being of our staff is the first and foremost priority, along with meeting patient needs and business continuity. We have been monitoring developments closely and preparing accordingly, and continue to do so," a spokesperson of the company was quoted saying news agency PTI.
A senior official of a pharma company based out of the city said they currently have orders on hand to be dispatched to some of the CIS countries following the developments between Russia and Ukraine.
"As of now there are no restrictions on pharma exports to any these countries. However, we want to wait for some time to get more clarity on how the situation will turn out. Ultimately our payments from those countries should not be affected as result of war," the official said on condition of anonymity.
When contacted, Udaya Bhaskar, Director General of Pharmexcil said the pharma body has neither received any communication from the Centre on export nor from drug makers on the state of affairs.
Never miss a story! Stay connected and informed with Mint. Download our App Now!!